These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21499112)

  • 1. Predictors of CD4 eligibility for antiretroviral therapy initiation among HIV-infected pregnant women in Lusaka, Zambia.
    Liu KC; Mulindwa J; Giganti MJ; Putta NB; Chintu N; Chi BH; Stringer JS; Stringer EM
    J Acquir Immune Defic Syndr; 2011 Aug; 57(5):e101-5. PubMed ID: 21499112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective study of HIV, antiretroviral therapy, and pregnancy-associated hypertension among women in Lusaka, Zambia.
    Stoner MC; Vwalika B; Smid MC; George S; Chi BH; Stringer EM; Stringer JS
    Int J Gynaecol Obstet; 2016 Sep; 134(3):299-303. PubMed ID: 27365290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Field effectiveness of combination antiretroviral prophylaxis for the prevention of mother-to-child HIV transmission in rural Zambia.
    Gartland MG; Chintu NT; Li MS; Lembalemba MK; Mulenga SN; Bweupe M; Musonda P; Stringer EM; Stringer JS; Chi BH
    AIDS; 2013 May; 27(8):1253-62. PubMed ID: 23324656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation and Operational Research: Integration of PMTCT and Antenatal Services Improves Combination Antiretroviral Therapy Uptake for HIV-Positive Pregnant Women in Southern Zambia: A Prototype for Option B+?
    Herlihy JM; Hamomba L; Bonawitz R; Goggin CE; Sambambi K; Mwale J; Musonda V; Musokatwane K; Hopkins KL; Semrau K; Hammond EE; Duncan J; Knapp AB; Thea DM
    J Acquir Immune Defic Syndr; 2015 Dec; 70(4):e123-9. PubMed ID: 26181813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low sensitivity of total lymphocyte count as a surrogate marker to identify antepartum and postpartum Indian women who require antiretroviral therapy.
    Gupta A; Gupte N; Bhosale R; Kakrani A; Kulkarni V; Nayak U; Thakar M; Sastry J; Bollinger RC;
    J Acquir Immune Defic Syndr; 2007 Nov; 46(3):338-42. PubMed ID: 17846559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
    AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa.
    Stinson K; Boulle A; Coetzee D; Abrams EJ; Myer L
    Trop Med Int Health; 2010 Jul; 15(7):825-32. PubMed ID: 20497405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
    PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonvirologic algorithms for predicting HIV infection among HIV-exposed infants younger than 12 weeks of age.
    Chi BH; Limbada MI; Giganti MJ; Li MS; Bweupe M; Musonda P; Bubala P; Mubiana-Mbewe M; Chintu NT; Bolton-Moore C; Stringer JS
    Pediatr Infect Dis J; 2013 Feb; 32(2):151-6. PubMed ID: 22935865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duration of cART Before Delivery and Low Infant Birthweight Among HIV-Infected Women in Lusaka, Zambia.
    Bengtson AM; Chibwesha CJ; Westreich D; Mubiana-Mbewe M; Vwalika B; Miller WC; Mapani M; Musonda P; Pettifor A; Chi BH
    J Acquir Immune Defic Syndr; 2016 Apr; 71(5):563-9. PubMed ID: 26627103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of mother-to-child transmission of HIV in Zambia: implementing efficacious ARV regimens in primary health centers.
    Mandala J; Torpey K; Kasonde P; Kabaso M; Dirks R; Suzuki C; Thompson C; Sangiwa G; Mukadi YD
    BMC Public Health; 2009 Aug; 9():314. PubMed ID: 19712454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does provision of point-of-care CD4 technology and early knowledge of CD4 levels affect early initiation and retention on antiretroviral treatment in HIV-positive pregnant women in the context of Option B+ for PMTCT?
    Mangwiro AZ; Makomva K; Bhattacharya A; Bhattacharya G; Gotora T; Owen M; Mushavi A; Mangwanya D; Zinyowera S; Rusakaniko S; Mugurungi O; Zizhou S; Busumani W; Masuka N
    J Acquir Immune Defic Syndr; 2014 Nov; 67 Suppl 2():S139-44. PubMed ID: 25310120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated prevention of mother-to-child HIV transmission services, antiretroviral therapy initiation, and maternal and infant retention in care in rural north-central Nigeria: a cluster-randomised controlled trial.
    Aliyu MH; Blevins M; Audet CM; Kalish M; Gebi UI; Onwujekwe O; Lindegren ML; Shepherd BE; Wester CW; Vermund SH
    Lancet HIV; 2016 May; 3(5):e202-11. PubMed ID: 27126487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying Gaps in Prevention of Mother to Child Transmission of HIV: A Case Series of HIV-positive Infants in Zambia.
    Bonawitz R; Sambambi K; Vickery M; Hamomba L; Hammond E; Duncan J; Musokotwane K; Thea D; Herlihy JM
    Pediatr Infect Dis J; 2016 Jul; 35(7):772-6. PubMed ID: 27093163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reuse of single-dose nevirapine in subsequent pregnancies for the prevention of mother-to-child HIV transmission in Lusaka, Zambia: a cohort study.
    Walter J; Kuhn L; Kankasa C; Semrau K; Sinkala M; Thea DM; Aldrovandi GM
    BMC Infect Dis; 2008 Dec; 8():172. PubMed ID: 19116004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
    Kowalska A; Niemiec T; El Midaoui A; Burkacka E
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanded services for the prevention of mother-to-child HIV transmission: field acceptability of a pilot program in Lusaka, Zambia.
    Chi BH; Chintu N; Lee A; Stringer EM; Sinkala M; Stringer JS
    J Acquir Immune Defic Syndr; 2007 May; 45(1):125-7. PubMed ID: 17460478
    [No Abstract]   [Full Text] [Related]  

  • 19. Implementation and Operational Research: Distance From Household to Clinic and Its Association With the Uptake of Prevention of Mother-to-Child HIV Transmission Regimens in Rural Zambia.
    Escamilla V; Chibwesha CJ; Gartland M; Chintu N; Mubiana-Mbewe M; Musokotwane K; Musonda P; Miller WC; Stringer JS; Chi BH
    J Acquir Immune Defic Syndr; 2015 Nov; 70(3):e94-e101. PubMed ID: 26470035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral treatment initiation among HIV-infected pregnant women with low CD4(+) cell counts in Gaborone, Botswana.
    Chen JY; Ogwu AC; Svab P; Lockman S; Moffat HJ; Gaolathe T; Moilwa S; Størdal K; Dryden-Peterson S; Moffat C; Makhema J; Essex M; Shapiro RL
    J Acquir Immune Defic Syndr; 2010 May; 54(1):102-6. PubMed ID: 19864957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.